Dr. Emad Kandil's Milestone: 100 Microwave Ablation Cases in Thyroid Care

In a significant milestone for the advancement of thyroid care, Dr. Emad Kandil, a renowned thyroid surgeon and professor at Tulane University School of Medicine, has completed 100 successful Microwave Ablation (MWA) procedures for thyroid nodules. This achievement highlights the growing adoption and clinical acceptance of MWA as a safe and effective alternative to traditional thyroid surgery, offering benefits such as faster recovery times, reduced procedural risks, and improved quality of life (Baird Medical Investment Holdings, 2025).

Dr. Kandil's expertise and experience in performing MWA procedures have contributed to the advancement of thyroid care. As a pioneer in the field, he has trained numerous physicians in MWA techniques, expanding access to this innovative treatment option. His work has been recognized with a Certificate of Excellence from Baird Medical, further validating his contributions to the field (Baird Medical Investment Holdings, 2025).

Moreover, Dr. Kandil's success with MWA has been highlighted in various conferences and publications, including the American Thyroid Association (ATA) annual meeting, where he presented the effectiveness of MWA compared to Radiofrequency Ablation (RFA) and shared clinical insights (Baird Medical Investment Holdings, 2024). This exposure has helped to raise awareness and promote the clinical acceptance of MWA among healthcare professionals.

In addition, Baird Medical, the leading provider of MWA technology, has sponsored advanced MWA training sessions led by Dr. Kandil. These sessions have provided hands-on experience with the cutting-edge treatment, offering patients faster recovery times and effective relief from thyroid nodules (Baird Medical, 2024). By investing in training programs and collaborating with physicians like Dr. Kandil, Baird Medical aims to foster collaboration and ensure more patients can benefit from advanced thyroid care.

The real value lies in the broader implications of MWA procedures. With an estimated 600,000 thyroid procedures performed annually in the US, even capturing 5% of this market could represent significant revenue potential. MWA procedures typically generate $3,000-5,000 in revenue per case, indicating substantial growth opportunities for providers (Baird Medical Investment Holdings, 2025).



For a company with a $316M market cap, individual physician milestones, while encouraging for clinical adoption, don't materially move the needle on financial projections or stock valuation. Investors should focus more on quarterly procedure volumes, reimbursement developments, and competitive positioning in the broader minimally invasive surgery market.

In conclusion, Dr. Emad Kandil's achievement of 100 successful MWA procedures has significantly contributed to the adoption and clinical acceptance of MWA technology in thyroid treatment. His expertise, training, and collaboration with Baird Medical have helped to raise awareness, promote clinical acceptance, and expand access to this innovative treatment option. As MWA continues to gain traction, its potential to generate significant revenue for providers and impact the broader minimally invasive surgery market is expected to grow.